Adhesion molecules in the pathophysiology of bullous diseases

European Journal of Dermatology

Volumn 6, Issue 6, 1996, Pages 399-405

  Kitajima, Yasuo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Cadherin; Desmosome; Hemidesmosome; Keratinocytes; Pemphigoid; Pemphigus

Indexed keywords

CELL ADHESION MOLECULE;

AUTOIMMUNITY; BLISTER; HUMAN; HUMAN TISSUE; PEMPHIGOID; PEMPHIGUS; REVIEW;

EID: 0029775071     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Stanley JR, Koulu L, Thivolet C. Distinction between epidermal antigens binding pemphigus vulqaris and pemphigus foliaceus autoantibodies. J Clin Invest 1984; 74: 313-20.
2. Koulu L, Kusumi A, Steinberg MS, Klaus-Kovtun V, Stanley JR. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med 1984; 160: 1509-18.
3. Stanley JR, Koulu L, Klaus-Kovtun V, Steinberg MS. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol 1986; 136: 1227-30.
4. Wheeler GN, Parker AE, Thomas CL, Ataliotis P, Poynter D, Arnemann J, Rutman AJ, Pidsley SC, Watt FM, Rees DA, Buxton RS, Magee AL. Desmosomal glycoprotein DGI, a component of intercellular desmosome junctions is related to the cadherin family of cell adhesion molecules. Proc Natl Acad Sci USA 1991; 88: 4796-800.
5. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphiqus vulqaris, a disease of cell adhesion. Cell 1991; 67: 869-77.
6. Amagai M, Karpati S, Pryssick R, Klaus-Kovtun V, Stanley JR. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992; 90: 919-26.
7. Amagai M, Hashimoto T, Shimizu N, Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by the baculovirus. J Clin Invest 1994; 94: 59-67.
8. Buxton RS, Cowin P, Franke WW, Garrod DR, Green KJ, Kinq IA, Koch PJ, Magee AI, Rees DA, Stanley JR, Steinberg MS. Nomenclature of the desmosomal cadherins. J Cell Biol 1993; 121: 481-3.
9. Stanley JR. Cell adhesions molecules as targets of autoantibodies in pemphigus and pemphigoid bullous diseases due to defective epidermal cell adhesion. Advances In Immunology 1992; 53: 291-325.
10. Legan PK, Collins JE, Garrod DR. The molecular biology of desmosomes and hemidesmosomes, "What's in a name ?" Bio Essay 1992; 14: 385-93.
11. Yue KKM, Holton JL, Clarke JP, Hyam JLM Hashmoto T, Chidgey MAJ, Garrod DR. Characterization of a desmocollin isoform (bovine DSC3) exclusively expressed in lower layers of stratified epithelia. J Cell Sci 1995; 108: 2163-73.
12. Collins JE, Legan PK, Kenny TP, MacGarvie J, Holton JL. Cloning and sequence analysis of desmosomal glycoproteins 2 and 3 (desmocollins): cadherin-like desmosomal adhesion molecules with heterogeneous cytoplasmic domains. J Cell Biol 1991; 113: 381-91.
13. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990; 59: 237-52.
14. Koch PJ, Goldschmidt MD, Zimbelmann R, Troyanovsky R, Franke WW. Complexity and expression patterns of the desmosomal cadherins. Proc Natl Acad Sci USA 1992; 89: 353-7.
15. Dmochowski M, Hashimoto T, Garrod DR, Nishikawa T. Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus. J Invest Dermatol 1993; 100: 380-4.
16. Dmochowski M, Hashimoto T, Chidgey MAJ, Yue KKM, Wilkinson RW, Nishikawa Y, Garrod DR. Demonstration of antibodies to bovine desmocollin isoforms in certain pemphigus sera. Br J Dermatol 1995; 133: 519-25.
17. Arnemann J, Sullivan KH, Magee AI, King IA, Buxton RS. Stratification-related expression of isoforms of the desmosomal cadherins in human epidermis. J Cell Sci 1993; 104: 741-50.
18. Shimizu H, Masunaga T, Ishiko A, Kikuchi A, Hashimoto T, Nishikawa T. Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded binding pattern to extracellular regions of demosomes in different layers of human epidermis. J Invest Dermatol 1995; 105: 153-9.
19. Amagai M, Koch PJ, Nishikawa T, Stanley JR. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol 1996; 106: 351-5.
20. Amagai M, Ishii K, Hashimoto T, Gamou S, Shimizu N, Nishikawa T. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J Invest Dermatol 1995; 105: 243-7.
21. Andrew P, Kowalczyk AP, Anderson JE, Borgwardt JE, Hashimoto T, Stanley JR, Green KJ. Pemphigus sera recognize conformationally sensitive epitopes in the amino-terminal region of desmoglein-1. J Invest Dermatol 1995; 105: 147-52.
22. Anhalt GJ, labib RS, Voorhees JJ, Beals TF, Diaz IA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982; 306: 1189-96.
23. Rock B, Labib RS, Diaz LA. Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal BALB/c mice. J Clin Invest 1990; 85: 296-9.
24. Seishima M, Esaki C, Osada K, Mori S, Hashimoto T, Kitajima Y. Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1, 4, 5-trisphosphate in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 1995; 104: 33-7.
25. Esaki C, Seishima M, Yamada T, Osada K, Kitajima Y. Pharmacological evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1, 4, 5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 1995; 105: 329-33.
26. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607-14.
27. Kitajima Y, Aoyama Y, Osada K, Seishima M, Owada MK. Substrate for phosphorylation by protein kinase C activated with pemphigus-IgG in cultured keratinocytes. J Invest Dermatol 1996; 106: 847.
28. Jones JCR, Yokoo KM, Goldman RD. Further analysis of pemphiqus autoantibodies and their use in studies on the heterogeneity, structure and function of desmosomes. J Cell Biol 1986; 102: 1109-17.
29. 2+ concentration. J Invest Dermatol1987; 89: 167-77.
30. Hashimoto K, Sharon KM, Webber PA, Lacers GS, Singer KH. Anti-cell surface pemphiqus antibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 1983; 157: 259-72.
31. Wilkinson JE, Smith CA, Suter MM, Fachek W, Lewis RM. Role of plasminogen activator in pemphigus vulgaris. Am J Pathol 1989; 134: 501-9.
32. Morioka S, Lazarus GS, Jensen PJ, Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG. J Invest Dermatol 1987; 89: 474-7.
33. Rosso MD, Fibbi G, Dini G, Grappone C, Pucci M, Caldini R, Magnelli L, Fimiani M, Lotti T, Panoconesi E. Role of specific membrane receptors in urokinase dependent migration of human keratinocytes. J Invest Dermatol 1990; 94: 310-6.
34. Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D. Isolation of complementary DNA for bullous pemphigoid antigen by use of patient's autoantibodies. J Clin Invest 1988; 82: 1864-70.
35. Tanaka T, Korman NJ, Shimizu H, Eady RAJA, Klaus-Kovtun V, Roop D. Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNA. J Invest Dermatol 1990; 94: 617-23.
36. Amagai M, Hashimoto T, Tajima S, Inokuchi Y, Shimizu N, Saito M, Miki K, Nishikawa T. Partial cDNA cloning of the 230 kDa mouse bullous pemphigoid antigen by the use of a human monoclonal antibasement membrane zone antibody. J Invest Dermatol 1990; 95: 252-9.
37. Shawamura D, Li K, Chu M-L, Uitto J. Human bullous pemphigoid antigen (BPAG1) amino acid sequenced from cloned cDNAs predict biologically important peptide segments and protein domains. J Biol Chem 191; 266: 17784-90.
38. Diaz LA, Ratire H III, Saunders WS, Futamura S, Squiquera HL, Anhalt GJ, Giudice GJ. Isolation of a human epidermal cDNA corresponding to the 180 kDa autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest 1990; 86: 1088-94.
39. Giudice GJ, Emery DJ, Diaz LA. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 1990; 99: 243-50.
40. Jones JC, Asmuth J, Baker SE, Langhofer M, Roth SI, Hopkinson SB. Hemidesmosomes: extracellular matirx/intermediate filament connectors. Exp Cell Res 1994; 213: 1-11.
41. Stepp MA, Spurr-Michaud S, Tisdalw A, Elwell J, Gipson IL. α6β4 integrin heterodimer is a component of hemidesmosomes. Proc Natl Acad Sci USA 1990; 87: 8970-4.
42. Giudice GJ, Squiquera PM, Elias PM, Diaze LA. Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest 1991; 87: 734-8.
43. Li K, Tamai K, Tan EML, Uitto J. Cloning of type XVII collagen. Complementary and genomic DNA sequence of mouse 180 kDa bullous pemphigoid antigen (BPGA2) predict in interrupted collagenous domain, a transmembrane segment, and unusual features in the 5′-end of the gene and the 3′-untranslated region of the mRNA. J Biol Chem 1993; 268: 8825-34.
44. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993; 92: 2480-8.
45. Green KJ Virata ML, Elgart GW, Stanley JR, Parry DAD. Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments. Int J Biol Macromol 1992; 14: 145-53.
46. Robledo MA, Kim SC, Korman NJ, Stanley JR, Labib RS, Futamura S, Anhalt GJ. Studies of the relationship of the 230 kDa and 180 kDa bullous pemphigoid antigens. J Invest Dermatol 1990; 94: 793-7.
47. Gaucherand M, Nicolas J-F, Baccala GP, Pouault J-P, Reano A, Magaud J-P, Thivolet J, Jolivet M, Schmitt D. Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C-terminal end of the protein. Evidence using a 55 kDa recombinant protein. Br J Dermatol 1995; 132: 190-6.
48. Giudice GJ, Emery DJ, Zelickson BD Anhalt GJ, Diaz LA. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 1993; 151: 5742-50.
49. Giudice GJ, Wilske KC, Anhalt GJ, Fairley JA, Taylor AF, Emery DJ, Hoffman RG, Diaz LA. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and heroes gestationis. J Invest Dermatol 1994; 102: 878-81.
50. Matsumura K, Amagai M, Nishikawa T, Hashimoto T. Majority of bullous pemphigoid and herpes gestationis sera react with NC16a domain of the 180 kDa bullous pemphigoid antigen. Arch Dermatol Res 1990 (in press).
51. Stanley JR. A specific antigen-antibody interaction triggers the cellular pathophysiology of bullous pemphigoid. Br J Dermatol 1985; 113 (Suppl. 28): 67-73.
52. Jordan RE, Kawana S, Frits KA. Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol 1985; 85: 72s-78s.
53. Grammom WR, Meritt CC, Levis DM, Sams WM, Carlo JR, Wheeler Jr CE. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol 1982; 78: 285-370.
54. Liu Z, Giudice GJ, Swartz SJ, Fairley LA, Till GO, Troy JL, Diaz LA. The role of complement in experimental bullous pemphigoid. J Clin Invest 1995; 95: 1539-44.
55. Kitajima Y, Owaribe K, Hirako, Owada MK, Yaoita H. Regulation of hemidesmosomes the mechanisms for the assembly of the 230 kDa and 180 kDa bullous pemphigoid antigens at dermal-epidermal junctions. In: Ishibashi Y, Nakagawa H, Suzuki H, eds. Electron microscopy in dermatology - basic and clinical research. Amsterdam: Elsevier Science BV, 1994: 111-20.
56. Kitajima Y, Hirako Y, Owaribe K, Yaoita H. A possible cell-biologic mechanism involved in blister formation of bullous pemphigoid: anti 180 kDa BPA antibody is an initiator. Dermatology 1994; 189 (Suppl. 1): 46-9.
57. Kitajima Y, Owaribe K, Nishizawa Y, Jokura Y, Yaoita H. Phorbol ester-and calcium-induced reorganization 180 kDa bullous pemphigoid antigen on the ventral surface of cultured human keratinocytes as studied by immunofluorescence and immunoelectron microscopy. Exp Cell Res 1992; 203: 17-24.
58. Kitajima Y, Hirako Y, Owaribe K, Mori S, Yaoita H. Antibody-binding to the 180 kDa bullous pemphigoid antigens at the lateral cell surface causes their internalization and inhibits their assembly at the basal cell surface in cultured keratinocytes. J Dermatol 1994; 21: 828-46.
59. Hopkinson SB, Baker SE, Jones JC. Molecular genetic studies of a human epidermal autoantigen (the 180 kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and α6 integrin. J Cell Biol 1995; 130: 117-25.